ZAS Pharma Ltd. proudly observes Epilepsy Awareness Month in November 2023, collaborating with the esteemed doctors of Bangabandhu Sheikh Mujib Medical University through their ‘Named Patient Access’ initiative. In a collective effort, they aim to heighten awareness about rare diseases, offering crucial support to those facing these challenges. Heartfelt gratitude is extended to the dedicated doctors and the ZAS team for their unwavering commitment to this cause. The ‘Named Patient Access’ division remains steadfast in its mission to bridge gaps and provide essential support for rare disease patients in Bangladesh, emphasizing ZAS Pharma’s dedication to making a meaningful impact in healthcare.

More Releases

Scroll to Top